Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment
Completed · Phase 2 · Has a placebo group
Conditions studied: Stroke, Muscle Spasticity
In brief
This study evaluates the responsiveness of 7 functional tasks to botulinum toxin Type A treatment in poststroke patients with spasticity of the upper-limb flexors
Key facts
- Study ID
- NCT00651690
- Run by
- Allergan
- People needed
- 62
- Starts
- 2004-03-01
- Expected to finish
- 2005-05-01
- Last updated by the study team
- 2008-05-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Medically stable poststroke with focal unilateral upper-limb spasticity
You may not qualify if…
- Stroke within 6 months of the study enrollment visit
- Previous or current botulinum toxin therapy of any type in the study limb
Where it is running
- Study site — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.